GGrantIndex
Sort

78,016 grants matching breast cancer

COMPLETE VARIANT PROFILING OF ALL KNOWN BREAST CANCER GENES

$614,351
Mary-Claire King · University Of Washington · R01 · FY2015 · CA

Protein and proteolytic activity biomarkers of early stage pancreatic cancer

$614,311
Paul Tempst · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

FFNP-PET as a predictive biomarker of response to endocrine therapy approaches in advanced breast cancer

$614,261
Kooresh Isaac Shoghi · Washington University · R01 · FY2023 · CA

Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)

$614,234
Robert J Gray · Dana-Farber Cancer Inst · U01 · FY2022 · CA

Genetics of Breast Cancer in Blacks

$614,200
University Of Chicago · R01 · FY2002 · CA

An Integrative Omics Approach to Identify Biomarkers Related to Preeclampsia and Breast Cancer Risks

$614,177
Lana X Garmire · University Of Hawaii At Manoa · R01 · FY2017 · HD

BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINS

$614,163
Margie Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2022 · CA

Disparity in Quality of Breast Cancer Treatment and Effects on Outcomes

$614,157
Jennifer J Griggs · University Of Michigan At Ann Arbor · R01 · FY2010 · CA

Risk Prediction for Breast Cancer: A Tissue-Based Strategy

$614,156
Lynn C. Hartmann · Mayo Clinic Rochester · R01 · FY2009 · CA

Transforming Cancer Knowledge, Attitudes and Behavior through Narrative

$614,138
Sheila T. Murphy · University Of Southern California · R01 · FY2009 · CA

Advancing breast cancer risk assessment with digital breast tomosynthesis

$614,113
Aimilia Gastounioti · Washington University · R01 · FY2025 · CA

Role of Eya3 in regulating the immune microenvironment to promote breast tumor progression

$614,111
Heide L Ford · University Of Colorado Denver · R01 · FY2017 · CA

Epithelial layer jamming in breast cancer cell migration

$614,103
Jeffrey J Fredberg · Harvard School Of Public Health · U01 · FY2016 · CA

Multilevel Resilience Trajectories in the Transition to Cancer Survivorship

$614,069
Crystal L Park · University Of Connecticut Storrs · UH3 · FY2019 · CA

Estimating Overdiagnosis in Cancer Screening Studies

$614,029
Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA

TARGETING CADHERIN 11 IN BASIL-LIKE, HORMONE-REFRACTORY BREAST CANCER

$614,000
Georgetown University · · FY2010 · Department of the Army

DNA Repair Deficiencies in Infertile Men and Cancer Risk

$613,983
Dolores Jean Lamb · Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2024 · CA

Programmable encapsulation systems to improve delivery of therapeutic bacteria

$613,945
Tal Danino · Columbia Univ New York Morningside · R01 · FY2023 · EB

PNI-BASED STRESS MANAGEMENT IN EARLY BREAST CANCER

$613,926
Virginia Commonwealth University · R01 · FY2005 · CA

TO PROVIDE BREAST AND CERVICAL CANCER SCREENING, FOLLOW-UP AND SUPPORT SERVICES F

$613,917
Lukas Noel Vanasse · Yukon-Kuskokwim Health Corporation · U58 · FY2012 · DP

LEGACY: A Cohort of Youth in Families from the Breast Cancer Family Registry

$613,906
Mary Beryl Daly · Research Inst Of Fox Chase Can Ctr · R01 · FY2013 · CA

Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms

$613,882
Mohamad Imad Damaj · Virginia Commonwealth University · R01 · FY2023 · CA

CYP2D6 gene variants and effectiveness of adjuvant tamoxifen in breast cancer

$613,849
Sheila A Weinmann · Kaiser Foundation Research Institute · R01 · FY2012 · CA

A Randomized Controlled Trial to Improve Health Insurance Literacy and Surveillance among Young Adult Cancer Survivors

$613,806
Anne C Kirchhoff · University Of Utah · R01 · FY2024 · CA

Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis

$613,781
Heide L Ford · University Of Colorado Denver · R01 · FY2021 · CA